| UniProt ID | ZN251_HUMAN | |
|---|---|---|
| UniProt AC | Q9BRH9 | |
| Protein Name | Zinc finger protein 251 | |
| Gene Name | ZNF251 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 671 | |
| Subcellular Localization | Nucleus . | |
| Protein Description | May be involved in transcriptional regulation.. | |
| Protein Sequence | MAATFQLPGHQEMPLTFQDVAVYFSQAEGRQLGPQQRALYRDVMLENYGNVASLGFPVPKPELISQLEQGKELWVLNLLGAEEPDILKSCQKDSEVGTKKELSILNQKFSEEVKTPEFVSRRLLRDNAQAAEFREAWGREGKLKERVGNSAGQSLNKPNIHKRVLTEATVGRERSLGERTQECSAFDRNLNLDQNVVRLQRNKTGERVFKCDICSKTFKYNSDLSRHQRSHTGEKPYECGRCGRAFTHSSNLVLHHHIHTGNKPFKCDECGKTFGLNSHLRLHRRIHTGEKPFGCGECGKAFSRSSTLIQHRIIHTGEKPYKCNECGRGFSQSPQLTQHQRIHTGEKPHECSHCGKAFSRSSSLIQHERIHTGEKPHKCNQCGKAFSQSSSLFLHHRVHTGEKPYVCNECGRAFGFNSHLTEHVRIHTGEKPYVCNECGKAFRRSSTLVQHRRVHTGEKPYQCVECGKAFSQSSQLTLHQRVHTGEKPYDCGDCGKAFSRRSTLIQHQKVHSGETRKCRKHGPAFVHGSSLTADGQIPTGEKHGRAFNHGANLILRWTVHTGEKSFGCNEYGKAFSPTSRPTEDQIMHAGEKPYKCQECGNAFSGKSTLIQHQVTHTGQKPCHCSVYGKAFSQSSQLTPPQQTRVGEKPALNDGSKRYFIHIKKIFQERHF | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 23 | Phosphorylation | TFQDVAVYFSQAEGR EHHHEEEEEEHHHCC | 6.43 | 30576742 | |
| 25 | Phosphorylation | QDVAVYFSQAEGRQL HHEEEEEEHHHCCCC | 15.70 | 30576742 | |
| 100 | Sumoylation | DSEVGTKKELSILNQ CCCCCCHHHHHHHHH | 64.82 | - | |
| 100 | Sumoylation | DSEVGTKKELSILNQ CCCCCCHHHHHHHHH | 64.82 | - | |
| 103 | Phosphorylation | VGTKKELSILNQKFS CCCHHHHHHHHHHHC | 26.56 | 23532336 | |
| 108 | Ubiquitination | ELSILNQKFSEEVKT HHHHHHHHHCHHCCC | 50.19 | 29967540 | |
| 114 | Sumoylation | QKFSEEVKTPEFVSR HHHCHHCCCHHHHHH | 62.74 | - | |
| 114 | Ubiquitination | QKFSEEVKTPEFVSR HHHCHHCCCHHHHHH | 62.74 | 29967540 | |
| 114 | Sumoylation | QKFSEEVKTPEFVSR HHHCHHCCCHHHHHH | 62.74 | 28112733 | |
| 115 | Phosphorylation | KFSEEVKTPEFVSRR HHCHHCCCHHHHHHH | 32.97 | 28555341 | |
| 154 | Phosphorylation | VGNSAGQSLNKPNIH HCCCCCCCCCCCCHH | 32.75 | 28555341 | |
| 157 | Sumoylation | SAGQSLNKPNIHKRV CCCCCCCCCCHHHHH | 44.74 | - | |
| 157 | Sumoylation | SAGQSLNKPNIHKRV CCCCCCCCCCHHHHH | 44.74 | 28112733 | |
| 162 | Sumoylation | LNKPNIHKRVLTEAT CCCCCHHHHHHHHHH | 40.17 | 28112733 | |
| 180 | Phosphorylation | ERSLGERTQECSAFD CCCHHHHHHHCCHHH | 25.15 | - | |
| 184 | Phosphorylation | GERTQECSAFDRNLN HHHHHHCCHHHCCCC | 31.08 | - | |
| 210 | Sumoylation | KTGERVFKCDICSKT CCCCEEEECCCCCCE | 28.30 | - | |
| 210 | Sumoylation | KTGERVFKCDICSKT CCCCEEEECCCCCCE | 28.30 | - | |
| 247 | Phosphorylation | GRCGRAFTHSSNLVL CCCCCCCCCCCCEEE | 21.62 | - | |
| 249 | Phosphorylation | CGRAFTHSSNLVLHH CCCCCCCCCCEEEEE | 20.19 | - | |
| 250 | Phosphorylation | GRAFTHSSNLVLHHH CCCCCCCCCEEEEEE | 26.95 | - | |
| 278 | Phosphorylation | GKTFGLNSHLRLHRR CCCCCCCHHHHHHHC | 29.01 | - | |
| 300 | Sumoylation | FGCGECGKAFSRSST CCCCCCCCCCCCCCC | 58.90 | - | |
| 300 | Sumoylation | FGCGECGKAFSRSST CCCCCCCCCCCCCCC | 58.90 | - | |
| 316 | Phosphorylation | IQHRIIHTGEKPYKC EEEEEEECCCCCEEC | 36.31 | 29496963 | |
| 319 | Ubiquitination | RIIHTGEKPYKCNEC EEEECCCCCEECCCC | 55.80 | - | |
| 333 | Phosphorylation | CGRGFSQSPQLTQHQ CCCCCCCCCCCCCCC | 17.26 | 25159151 | |
| 362 | Phosphorylation | GKAFSRSSSLIQHER CCCCCCCCCHHHHCC | 28.22 | 27251275 | |
| 363 | Phosphorylation | KAFSRSSSLIQHERI CCCCCCCCHHHHCCC | 30.64 | 28555341 | |
| 400 | Phosphorylation | FLHHRVHTGEKPYVC EEEEEECCCCCCEEE | 44.15 | - | |
| 403 | Sumoylation | HRVHTGEKPYVCNEC EEECCCCCCEEECCC | 42.89 | 28112733 | |
| 403 | Sumoylation | HRVHTGEKPYVCNEC EEECCCCCCEEECCC | 42.89 | - | |
| 428 | Phosphorylation | TEHVRIHTGEKPYVC CCCEEEECCCCCEEE | 44.67 | 28111955 | |
| 456 | Phosphorylation | VQHRRVHTGEKPYQC HCCCCCCCCCCCEEE | 44.15 | - | |
| 484 | Phosphorylation | TLHQRVHTGEKPYDC EEEEEECCCCCCCCC | 44.15 | - | |
| 487 | Ubiquitination | QRVHTGEKPYDCGDC EEECCCCCCCCCCCC | 50.66 | - | |
| 496 | Sumoylation | YDCGDCGKAFSRRST CCCCCCCHHCCCCCH | 53.22 | - | |
| 496 | Sumoylation | YDCGDCGKAFSRRST CCCCCCCHHCCCCCH | 53.22 | - | |
| 520 | Ubiquitination | GETRKCRKHGPAFVH CCCCHHHCCCCCEEE | 63.48 | 29967540 | |
| 522 | Phosphorylation | TRKCRKHGPAFVHGS CCHHHCCCCCEEECC | 20.47 | 15302935 | |
| 565 | Phosphorylation | TVHTGEKSFGCNEYG EEECCCCCCCCCCCC | 23.67 | 22817900 | |
| 576 | Phosphorylation | NEYGKAFSPTSRPTE CCCCCCCCCCCCCCH | 31.93 | 25159151 | |
| 582 | Phosphorylation | FSPTSRPTEDQIMHA CCCCCCCCHHHHCCC | 51.59 | 22210691 | |
| 595 | Sumoylation | HAGEKPYKCQECGNA CCCCCCCCCCCCCCC | 37.66 | - | |
| 595 | Sumoylation | HAGEKPYKCQECGNA CCCCCCCCCCCCCCC | 37.66 | - | |
| 648 | Ubiquitination | QQTRVGEKPALNDGS CCCCCCCCCCCCCCC | 29.66 | 29967540 | |
| 648 | Sumoylation | QQTRVGEKPALNDGS CCCCCCCCCCCCCCC | 29.66 | - | |
| 648 | Sumoylation | QQTRVGEKPALNDGS CCCCCCCCCCCCCCC | 29.66 | - | |
| 658 | Phosphorylation | LNDGSKRYFIHIKKI CCCCCCEEEEEEHHH | 15.60 | - | |
| 664 | Sumoylation | RYFIHIKKIFQERHF EEEEEEHHHHHHCCC | 48.42 | - | |
| 664 | Sumoylation | RYFIHIKKIFQERHF EEEEEEHHHHHHCCC | 48.42 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ZN251_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ZN251_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ZN251_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
Oops, there are no PPI records of ZN251_HUMAN !! | ||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...